SMMT Stock Analysis: Buy, Sell, or Hold?
SMMT - Summit Therapeutics Inc. Common Stock
$13.21
0.19 (1.46%)
▲
5d:
+0.8%
30d:
-14.33%
90d:
-18.03%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Oct 19, 2026
Smart Money Accumulation
None View Scanner →
Strength: 6.1/10
Get Alerted When SMMT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SMMT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: SMMT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: SMMT is currently trading at $13.21, which is considered oversold relative to its 30-day fair value range of $13.38 to $15.36.
Technical Outlook: Technically, SMMT is in a strong uptrend. Immediate support is located at $12.25, while resistance sits at $15.71.
Market Sentiment: SMMT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $28.31 (+117.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SMMT is in a strong uptrend. Immediate support is located at $12.25, while resistance sits at $15.71.
Market Sentiment: SMMT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $28.31 (+117.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$13.38 -
$15.36
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 117.4% below Wall St target ($28.31)
Trading Range Analysis
30-Day Trading Range
$13.38 -
$15.36
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$12.25
Resistance Level
$15.71
Current Trend
Strong Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-14.65
Wall Street Target
$28.31
(+117.4%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: August 03, 2026 3:31 PM ET
Data refreshes hourly during market hours. Next update: 4:31 PM
Data refreshes hourly during market hours. Next update: 4:31 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SMMT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 53 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$282 | 54 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$33 | 60 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$105 | 56 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$123 | 59 HOLD |
